CORMEDIX INC. Warrant To Purchase Common StockCorMedix Inc. • November 13th, 2017 • Pharmaceutical preparations • New York
This Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”) of CorMedix Inc. (the “Company”) is issued this __ day of November, 2017 (the “Issuance Date”) to [ ] (the “Holder”) pursuant to that certain Backstop Agreement, dated the Issuance Date (the “Backstop Agreement”). The Company hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Holder or its permitted assigns is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant, at any time or times on or after the Issue Date (the “Initial Exercisability Date”), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), a number of shares of Common Stock equal to [ ]% of the Aggregate Warrant Amount (subject to adjustment as provided herein)
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 13th, 2017 • CorMedix Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of November __, 2017, by and between (i) CorMedix Inc., a Delaware corporation (the “Company”), and (ii) Elliott International, L.P. and Elliott Associates, L.P. (collectively, “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2017 • CorMedix Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 9, 2017, is by and among CorMedix Inc., a Delaware corporation with offices located at 400 Connell Drive, 5th Floor, Berkeley Heights, NJ 07922 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
BACKSTOP AGREEMENTBackstop Agreement • November 13th, 2017 • CorMedix Inc. • Pharmaceutical preparations • New York
This BACKSTOP AGREEMENT (this “Agreement”), dated as of November 9, 2017, is entered into by and between CorMedix Inc., a Delaware corporation with offices located at 400 Connell Drive, 5th Floor, Berkeley Heights, NJ 07922 (the ”Company”), and the backstop investors signatory hereto (collectively, the “Backstop Investors”). Capitalized terms used but not defined herein shall have the meanings assigned thereto in that certain Securities Purchase Agreement, dated as of the date hereof (the “Purchase Agreement”), between the Company, the Backstop Investors and the other investors party thereto from time to time.
